Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand, but empirical data on the association of increased prescribing of GLP-1 [receptor agonists] with use of metabolic bariatric surgery is unavailable, to our knowledge, Kevin Lin, BA, from Harvard Medical School, and colleagues wrote in JAMA Network Open
At Envizion Medical , we specialize in personalized strategies for weight loss, hormone health, and longevity
Make an appointment with us today!
doi: 10.1016/j.nut.2010.07.021 15 EisenbaumM.PearsonA.GratkowskiA.MouzonB.MullanM.CrawfordF.et al
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis
Please enable javascript